(Q23919737)

7

object named as

J. E. Snawder

0 references

Raymond E. Biagini

1

object named as

R. E. Biagini

0 references

author name string

D. L. Sammons

2

0 references

J. P. Smith

3

0 references

B. A. MacKenzie

4

0 references

C. A. F. Striley

5

0 references

S. A. Robertson

Analytical and Bioanalytical Chemistry

6

0 references

language of work or name

English

0 references

publication date

2 June 2005

0 references

published in

0 references

volume

382

0 references

issue

4

0 references

page(s)

1027-1034

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

funding scheme

interagency agreement

1 reference

25 September 2023

Immunological characteristics associated with the protective efficacy of antibodies to ricin

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

Ribosome-inactivating proteins from plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

Anthrax as a potential biological warfare agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Tularemia vaccine study. I. Intracutaneous challenge

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Tularemia vaccine study. II. Respiratory challenge

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Tularemia as a biological weapon: medical and public health management

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Serodiagnosis of human plague by a combination of immunomagnetic separation and flow cytometry

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Production and purification of a recombinant Staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

A case of primary tularemic pneumonia presenting with necrotizing mediastinal and hilar lymph nodes

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Development of a sensitivity enhanced multiplexed fluorescence covalent microbead immunosorbent assay (FCMIA) for the measurement of glyphosate, atrazine and metolachlor mercapturate in water and urine

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Immunisation against plague by transcutaneous and intradermal application of subunit antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

A novel recombinant vaccine which protects mice against ricin intoxication.

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Serodiagnosis of infectious diseases with antigen microarrays

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Recognition and management of anthrax--an update

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Analysis of adverse events after anthrax immunization in US Army medical personnel

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Production of antibodies to staphylococcal superantigens in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Validation of serological assays for diagnosis of infectious diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021

Epidemiology of bioterrorism

1 reference

https://api.crossref.org/works/10.1007%2FS00216-005-3204-6

7 January 2021